Thiogenesis Therapeutics, Corp. funding
Thiogenesis Therapeutics, Corp., a biotechnology company based in Toronto, Ontario, Canada, filed a Form D with the SEC on June 9, 2026 and reported $29K raised.
Amount raised$29K
Offering size$29K
Filed with the SECJune 9, 2026
First saleJune 1, 2026
IndustryBiotechnology
SecuritiesEquity
LocationToronto, Ontario, Canada
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far0
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 9
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology